QA: Tvardi Therapeutics Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001346830_2017_Tvardi_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001346830, Tvardi Therapeutics Inc

  xvar xval
0 AssetsCurrent 61,445,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,614,000
3 remainder_Assets 769,000
4 LiabilitiesCurrent 11,533,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,233,000
9 ResearchAndDevelopmentExpense 49,253,000
10 remainder_Expenses -468,000
11 remainder_Revenues 86,000
12 remainder_NetIncome 652,000
13 remainder_ComprehensiveNetIncome 38,000
  yvar yval
0 Assets 63,828,000
1 Liabilities 11,533,000
2 Expenses 58,018,000
3 Revenues 86,000
4 StockholdersEquity 52,295,000
5 NetIncome -57,280,000
6 ComprehensiveNetIncome -57,261,000
7 BaseVar 67,077,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.51
9 EconomicCapitalRatio 2.68

Edgar->Model Mapping

Feature Distribution

Change over Time